Publikace
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | 1. lékařská fakulta, 2. lékařská fakulta
- Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients2016 | 1. lékařská fakulta, 2. lékařská fakulta
- Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma2015 | 1. lékařská fakulta, 2. lékařská fakulta, Přírodovědecká fakulta
- Flt3 ligand expands CD4+FoxP3+regulatory T cells in human subjects2013 | 2. lékařská fakulta
- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta
- Type I interferon and cancer2024 | 2. lékařská fakulta
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma2023 | 1. lékařská fakulta, 2. lékařská fakulta
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | 2. lékařská fakulta
- Interferon signaling restrains renal cell carcinoma heterogeneity2023 | 2. lékařská fakulta
Loading network view...
